WHO WE ARE
FCF is a specialized Investment Bank and Financing Specialist, advising public and private small/mid-market companies in the German speaking regions.
FCF focuses on four primary client segments:
- Mid-Cap: Medium-sized companies with sustainable business models in typical “Mittelstand” industries, such as industrial products and machinery, automotive, communications, logistics, and consumer products
- Deep-Tech: R&D-driven companies in technology sectors, entering the commercialization stage with initial fast-growing revenues
- Growth / Small-Cap: Companies with revenues greater €25 million and high / above average growth rates
- Life Sciences: Highly innovative companies focusing on the development of cutting-edge biotechnology, med-tech, health-tech and pharmaceuticals solutions
FCF structures, arranges and places equity and debt capital transactions and supports its clients’ growth, IPO/Pre-IPO, acquisition and standard balance sheet (re-)financing strategies.
Founded in 2005 and headquartered in Munich, FCF has direct relationships and works with all leading German, European and international financiers, lenders and investors address-ing German small/mid-cap companies.
WHO WE SERVE
WHAT WE DO
(click below for details)
- with the best conditions,
- with the highest flexibility,
- in the shortest period of time,
- with the highest closing probability,
- with long-lasting financial partners that suit the company’s objectives.
- Deep knowledge and understanding of all relevant financial instruments across the debt and equity space:
- 360-degree perspective, offering maximum independence and freedom
- Complete financial markets insight with direct access to all relevant institutional investors and financiers
- Strategic approach in searching and selecting suitable investors
- Development, structuring and placing of comprehensive financial solutions combined with targeted financing measures
- The most creative team, specialized in the financing of SMEs
- Proactive, independent process management for strengthened negotiation leverage
- Focus on SMEs in the DACH region
- Quintessential medium-sized companies (“Mittelstand”) with revenues between EUR 100m and EUR 1,000m
- Fast growing companies operating established and proven business models
- Ultra-high growth, innovative companies with revolutionary technologies / products, for instance in life science and high-tech
- Access to & established network with the largest families, family offices and Ultra High Net Worth investors
- Discrete, bilateral discussions behind closed doors
- Direct investments with entrepreneurial and co-operative approach
- Long-term investment horizons all the way to evergreen funding
- Direct access to key executives at all top-tier and mid-sized investment banks
- to the market-leading, market-influencing sector experts
- to investment banking, capital markets and research departments
- Top-tier institutional US investors with focus on and interest in DACH enterprises
- Contact to selected “high profile” Ultra High Net Worth investors and family offices
- Exclusive dialog with the entrepreneurs / owners
- 100% focus on the requirements and interests
- Confidant and creative motivator in the decision-making process
- Maximization of alternative courses of action
RECENT TRANSACTIONS
Vasopharm GmbH
Transaction Support
July 2019
[amount confidential]
July 2019
[amount confidential]
Hydrogenious LOHC Technologies GmbH
Capital Increase
July 2019
€ 17 million
July 2019
€ 17 million
Doppstadt Familienholding GmbH
Syndicated Loan, Factoring and Warehousing Facility
June 2019
€ 80 million
June 2019
€ 80 million
Synapticon GmbH
Round-Extension
June 2019
[amount confidential]
June 2019
[amount confidential]
